Long-term health study in Ezhou focusing on chronic diseases
Tongji-Ezhou Prospectively Cohort Study
This study is trying to see how diet and environment affect long-term health by following 10,000 people in Ezhou for 20 years and checking their blood for signs of chronic diseases.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 20 Years to 80 Years |
| Sex | All |
| Sponsor | Huazhong University of Science and Technology Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Wuhan, Hubei) |
| Trial ID | NCT03845868 on ClinicalTrials.gov |
What this trial studies
The Tongji-Ezhou study is a prospective cohort study initiated in 2013 in Ezhou city, Hubei province, aiming to recruit and follow 10,000 individuals for at least 20 years. The study will collect blood samples from 6,000 participants every 3-5 years to analyze nutritional biomarkers and identify potential determinants of chronic diseases such as obesity, type 2 diabetes, metabolic syndrome, and cardiovascular diseases. This observational approach will help in understanding the long-term effects of dietary and environmental exposures on health outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 20 years and older who have been permanent residents of Ezhou district for at least 9 months.
Not a fit: Patients undergoing chemotherapy or radiotherapy for cancer or those with other severe diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the prevention and management of chronic diseases through dietary and lifestyle modifications.
How similar studies have performed: Other long-term cohort studies have shown success in identifying risk factors for chronic diseases, suggesting that this approach is promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * (i) permanent residence in Ezhou district (minimum of 9 months); (ii) written informed consent; (iii) age ≥ 20 years old at the time of enrolling in the study. Exclusion Criteria: * (i) with chemotherapy or radiotherapy for cancer and other severe diseases.
Where this trial is running
Wuhan, Hubei
- Huazhong University of Science and Technology — Wuhan, Hubei, China (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.